Transgender and gender diverse individuals face lower follow-up rates after psychiatric hospitalization

Transgender and gender diverse individuals who were hospitalized for psychiatric care were less likely to have a follow-up visit compared to the general population, suggesting they face transphobia in the hospital system.

Europe lines up first CRISPR therapy approval

Following FDA approval, Vertex Pharmaceuticals and CRISPR Therapeutics on Friday received a positive recommendation for a conditional approval by a key European medicines panel for

December 16, 2023

Research uncovers dietary patterns influencing Mediterranean Diet adherence

Portuguese researchers explore olive oil consumption and adherence to the Mediterranean Diet, revealing key barriers and consumer patterns. The findings highlight the need for tailored

December 10, 2024

Freeline’s early Gaucher disease data; Shorla raises $35M; Regenxbio to start pivotal DMD trial next year

Freeline’s early data on gene therapy for Gaucher disease: Freeline Therapeutics said Wednesday that its gene therapy for Gaucher disease looked safe so far in

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.